Global Pneumonia Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Pneumonia Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Pneumonia is a lung infection that occurs in one or both the lungs caused by bacteria, viruses, or fungi; however, bacterial pneumonia is the most common form occurring in adults. Center for Disease Control and Prevention (CDC) recommends administration of two pneumococcal vaccines.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Pneumonia Vaccine industry chain, the market status of Pneumonia (Pneumococcal Conjugate Vaccine (PCV13), Pneumococcal Polysaccharide Vaccine (PPSV23)), Meningitis (Pneumococcal Conjugate Vaccine (PCV13), Pneumococcal Polysaccharide Vaccine (PPSV23)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Pneumonia Vaccine.
Regionally, the report analyzes the Pneumonia Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Pneumonia Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Pneumonia Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Pneumonia Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Doses), revenue generated, and market share of different by Type (e.g., Pneumococcal Conjugate Vaccine (PCV13), Pneumococcal Polysaccharide Vaccine (PPSV23)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Pneumonia Vaccine market.
Regional Analysis: The report involves examining the Pneumonia Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Pneumonia Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Pneumonia Vaccine:
Company Analysis: Report covers individual Pneumonia Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Pneumonia Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pneumonia, Meningitis).
Technology Analysis: Report covers specific technologies relevant to Pneumonia Vaccine. It assesses the current state, advancements, and potential future developments in Pneumonia Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Pneumonia Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Pneumonia Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Pneumonia Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pneumonia Vaccine, with price, sales, revenue and global market share of Pneumonia Vaccine from 2019 to 2024.
Chapter 3, the Pneumonia Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pneumonia Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Pneumonia Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pneumonia Vaccine.
Chapter 14 and 15, to describe Pneumonia Vaccine sales channel, distributors, customers, research findings and conclusion.
Pneumonia is a lung infection that occurs in one or both the lungs caused by bacteria, viruses, or fungi; however, bacterial pneumonia is the most common form occurring in adults. Center for Disease Control and Prevention (CDC) recommends administration of two pneumococcal vaccines.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Pneumonia Vaccine industry chain, the market status of Pneumonia (Pneumococcal Conjugate Vaccine (PCV13), Pneumococcal Polysaccharide Vaccine (PPSV23)), Meningitis (Pneumococcal Conjugate Vaccine (PCV13), Pneumococcal Polysaccharide Vaccine (PPSV23)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Pneumonia Vaccine.
Regionally, the report analyzes the Pneumonia Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Pneumonia Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Pneumonia Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Pneumonia Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Doses), revenue generated, and market share of different by Type (e.g., Pneumococcal Conjugate Vaccine (PCV13), Pneumococcal Polysaccharide Vaccine (PPSV23)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Pneumonia Vaccine market.
Regional Analysis: The report involves examining the Pneumonia Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Pneumonia Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Pneumonia Vaccine:
Company Analysis: Report covers individual Pneumonia Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Pneumonia Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pneumonia, Meningitis).
Technology Analysis: Report covers specific technologies relevant to Pneumonia Vaccine. It assesses the current state, advancements, and potential future developments in Pneumonia Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Pneumonia Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Pneumonia Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Pneumococcal Conjugate Vaccine (PCV13)
- Pneumococcal Polysaccharide Vaccine (PPSV23)
- Other
- Pneumonia
- Meningitis
- Sepsis
- Pfizer Inc.
- Glaxosmithkline Plc.
- Merck & Co., Inc.
- Sanofi Pasteur
- Serum Institute of India Pvt. Ltd.
- Johnson & Johnson
- Astellas Pharma Inc.
- Astrazeneca Plc.
- CSL Limited
- Emergent Biosolutions
- Walvax Biotechnology
- Royal (Wuxi) Bio-Pharmaceutical
- Zhifei Biologic
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Pneumonia Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pneumonia Vaccine, with price, sales, revenue and global market share of Pneumonia Vaccine from 2019 to 2024.
Chapter 3, the Pneumonia Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pneumonia Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Pneumonia Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pneumonia Vaccine.
Chapter 14 and 15, to describe Pneumonia Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Pneumonia Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Pneumonia Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Pneumococcal Conjugate Vaccine (PCV13)
1.3.3 Pneumococcal Polysaccharide Vaccine (PPSV23)
1.3.4 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Pneumonia Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Pneumonia
1.4.3 Meningitis
1.4.4 Sepsis
1.5 Global Pneumonia Vaccine Market Size & Forecast
1.5.1 Global Pneumonia Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Pneumonia Vaccine Sales Quantity (2019-2030)
1.5.3 Global Pneumonia Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Pfizer Inc.
2.1.1 Pfizer Inc. Details
2.1.2 Pfizer Inc. Major Business
2.1.3 Pfizer Inc. Pneumonia Vaccine Product and Services
2.1.4 Pfizer Inc. Pneumonia Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Pfizer Inc. Recent Developments/Updates
2.2 Glaxosmithkline Plc.
2.2.1 Glaxosmithkline Plc. Details
2.2.2 Glaxosmithkline Plc. Major Business
2.2.3 Glaxosmithkline Plc. Pneumonia Vaccine Product and Services
2.2.4 Glaxosmithkline Plc. Pneumonia Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Glaxosmithkline Plc. Recent Developments/Updates
2.3 Merck & Co., Inc.
2.3.1 Merck & Co., Inc. Details
2.3.2 Merck & Co., Inc. Major Business
2.3.3 Merck & Co., Inc. Pneumonia Vaccine Product and Services
2.3.4 Merck & Co., Inc. Pneumonia Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Merck & Co., Inc. Recent Developments/Updates
2.4 Sanofi Pasteur
2.4.1 Sanofi Pasteur Details
2.4.2 Sanofi Pasteur Major Business
2.4.3 Sanofi Pasteur Pneumonia Vaccine Product and Services
2.4.4 Sanofi Pasteur Pneumonia Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Sanofi Pasteur Recent Developments/Updates
2.5 Serum Institute of India Pvt. Ltd.
2.5.1 Serum Institute of India Pvt. Ltd. Details
2.5.2 Serum Institute of India Pvt. Ltd. Major Business
2.5.3 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Product and Services
2.5.4 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Serum Institute of India Pvt. Ltd. Recent Developments/Updates
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Pneumonia Vaccine Product and Services
2.6.4 Johnson & Johnson Pneumonia Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Johnson & Johnson Recent Developments/Updates
2.7 Astellas Pharma Inc.
2.7.1 Astellas Pharma Inc. Details
2.7.2 Astellas Pharma Inc. Major Business
2.7.3 Astellas Pharma Inc. Pneumonia Vaccine Product and Services
2.7.4 Astellas Pharma Inc. Pneumonia Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Astellas Pharma Inc. Recent Developments/Updates
2.8 Astrazeneca Plc.
2.8.1 Astrazeneca Plc. Details
2.8.2 Astrazeneca Plc. Major Business
2.8.3 Astrazeneca Plc. Pneumonia Vaccine Product and Services
2.8.4 Astrazeneca Plc. Pneumonia Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Astrazeneca Plc. Recent Developments/Updates
2.9 CSL Limited
2.9.1 CSL Limited Details
2.9.2 CSL Limited Major Business
2.9.3 CSL Limited Pneumonia Vaccine Product and Services
2.9.4 CSL Limited Pneumonia Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 CSL Limited Recent Developments/Updates
2.10 Emergent Biosolutions
2.10.1 Emergent Biosolutions Details
2.10.2 Emergent Biosolutions Major Business
2.10.3 Emergent Biosolutions Pneumonia Vaccine Product and Services
2.10.4 Emergent Biosolutions Pneumonia Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Emergent Biosolutions Recent Developments/Updates
2.11 Walvax Biotechnology
2.11.1 Walvax Biotechnology Details
2.11.2 Walvax Biotechnology Major Business
2.11.3 Walvax Biotechnology Pneumonia Vaccine Product and Services
2.11.4 Walvax Biotechnology Pneumonia Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Walvax Biotechnology Recent Developments/Updates
2.12 Royal (Wuxi) Bio-Pharmaceutical
2.12.1 Royal (Wuxi) Bio-Pharmaceutical Details
2.12.2 Royal (Wuxi) Bio-Pharmaceutical Major Business
2.12.3 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Product and Services
2.12.4 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Royal (Wuxi) Bio-Pharmaceutical Recent Developments/Updates
2.13 Zhifei Biologic
2.13.1 Zhifei Biologic Details
2.13.2 Zhifei Biologic Major Business
2.13.3 Zhifei Biologic Pneumonia Vaccine Product and Services
2.13.4 Zhifei Biologic Pneumonia Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Zhifei Biologic Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PNEUMONIA VACCINE BY MANUFACTURER
3.1 Global Pneumonia Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Pneumonia Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Pneumonia Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Pneumonia Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Pneumonia Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Pneumonia Vaccine Manufacturer Market Share in 2023
3.5 Pneumonia Vaccine Market: Overall Company Footprint Analysis
3.5.1 Pneumonia Vaccine Market: Region Footprint
3.5.2 Pneumonia Vaccine Market: Company Product Type Footprint
3.5.3 Pneumonia Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Pneumonia Vaccine Market Size by Region
4.1.1 Global Pneumonia Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Pneumonia Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Pneumonia Vaccine Average Price by Region (2019-2030)
4.2 North America Pneumonia Vaccine Consumption Value (2019-2030)
4.3 Europe Pneumonia Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Pneumonia Vaccine Consumption Value (2019-2030)
4.5 South America Pneumonia Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Pneumonia Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Pneumonia Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Pneumonia Vaccine Consumption Value by Type (2019-2030)
5.3 Global Pneumonia Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Pneumonia Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Pneumonia Vaccine Consumption Value by Application (2019-2030)
6.3 Global Pneumonia Vaccine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Pneumonia Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Pneumonia Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Pneumonia Vaccine Market Size by Country
7.3.1 North America Pneumonia Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Pneumonia Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Pneumonia Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Pneumonia Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Pneumonia Vaccine Market Size by Country
8.3.1 Europe Pneumonia Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Pneumonia Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Pneumonia Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Pneumonia Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Pneumonia Vaccine Market Size by Region
9.3.1 Asia-Pacific Pneumonia Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Pneumonia Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Pneumonia Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Pneumonia Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Pneumonia Vaccine Market Size by Country
10.3.1 South America Pneumonia Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Pneumonia Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Pneumonia Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Pneumonia Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Pneumonia Vaccine Market Size by Country
11.3.1 Middle East & Africa Pneumonia Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Pneumonia Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Pneumonia Vaccine Market Drivers
12.2 Pneumonia Vaccine Market Restraints
12.3 Pneumonia Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Pneumonia Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pneumonia Vaccine
13.3 Pneumonia Vaccine Production Process
13.4 Pneumonia Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pneumonia Vaccine Typical Distributors
14.3 Pneumonia Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Pneumonia Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Pneumonia Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Pneumococcal Conjugate Vaccine (PCV13)
1.3.3 Pneumococcal Polysaccharide Vaccine (PPSV23)
1.3.4 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Pneumonia Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Pneumonia
1.4.3 Meningitis
1.4.4 Sepsis
1.5 Global Pneumonia Vaccine Market Size & Forecast
1.5.1 Global Pneumonia Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Pneumonia Vaccine Sales Quantity (2019-2030)
1.5.3 Global Pneumonia Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Pfizer Inc.
2.1.1 Pfizer Inc. Details
2.1.2 Pfizer Inc. Major Business
2.1.3 Pfizer Inc. Pneumonia Vaccine Product and Services
2.1.4 Pfizer Inc. Pneumonia Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Pfizer Inc. Recent Developments/Updates
2.2 Glaxosmithkline Plc.
2.2.1 Glaxosmithkline Plc. Details
2.2.2 Glaxosmithkline Plc. Major Business
2.2.3 Glaxosmithkline Plc. Pneumonia Vaccine Product and Services
2.2.4 Glaxosmithkline Plc. Pneumonia Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Glaxosmithkline Plc. Recent Developments/Updates
2.3 Merck & Co., Inc.
2.3.1 Merck & Co., Inc. Details
2.3.2 Merck & Co., Inc. Major Business
2.3.3 Merck & Co., Inc. Pneumonia Vaccine Product and Services
2.3.4 Merck & Co., Inc. Pneumonia Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Merck & Co., Inc. Recent Developments/Updates
2.4 Sanofi Pasteur
2.4.1 Sanofi Pasteur Details
2.4.2 Sanofi Pasteur Major Business
2.4.3 Sanofi Pasteur Pneumonia Vaccine Product and Services
2.4.4 Sanofi Pasteur Pneumonia Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Sanofi Pasteur Recent Developments/Updates
2.5 Serum Institute of India Pvt. Ltd.
2.5.1 Serum Institute of India Pvt. Ltd. Details
2.5.2 Serum Institute of India Pvt. Ltd. Major Business
2.5.3 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Product and Services
2.5.4 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Serum Institute of India Pvt. Ltd. Recent Developments/Updates
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Pneumonia Vaccine Product and Services
2.6.4 Johnson & Johnson Pneumonia Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Johnson & Johnson Recent Developments/Updates
2.7 Astellas Pharma Inc.
2.7.1 Astellas Pharma Inc. Details
2.7.2 Astellas Pharma Inc. Major Business
2.7.3 Astellas Pharma Inc. Pneumonia Vaccine Product and Services
2.7.4 Astellas Pharma Inc. Pneumonia Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Astellas Pharma Inc. Recent Developments/Updates
2.8 Astrazeneca Plc.
2.8.1 Astrazeneca Plc. Details
2.8.2 Astrazeneca Plc. Major Business
2.8.3 Astrazeneca Plc. Pneumonia Vaccine Product and Services
2.8.4 Astrazeneca Plc. Pneumonia Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Astrazeneca Plc. Recent Developments/Updates
2.9 CSL Limited
2.9.1 CSL Limited Details
2.9.2 CSL Limited Major Business
2.9.3 CSL Limited Pneumonia Vaccine Product and Services
2.9.4 CSL Limited Pneumonia Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 CSL Limited Recent Developments/Updates
2.10 Emergent Biosolutions
2.10.1 Emergent Biosolutions Details
2.10.2 Emergent Biosolutions Major Business
2.10.3 Emergent Biosolutions Pneumonia Vaccine Product and Services
2.10.4 Emergent Biosolutions Pneumonia Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Emergent Biosolutions Recent Developments/Updates
2.11 Walvax Biotechnology
2.11.1 Walvax Biotechnology Details
2.11.2 Walvax Biotechnology Major Business
2.11.3 Walvax Biotechnology Pneumonia Vaccine Product and Services
2.11.4 Walvax Biotechnology Pneumonia Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Walvax Biotechnology Recent Developments/Updates
2.12 Royal (Wuxi) Bio-Pharmaceutical
2.12.1 Royal (Wuxi) Bio-Pharmaceutical Details
2.12.2 Royal (Wuxi) Bio-Pharmaceutical Major Business
2.12.3 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Product and Services
2.12.4 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Royal (Wuxi) Bio-Pharmaceutical Recent Developments/Updates
2.13 Zhifei Biologic
2.13.1 Zhifei Biologic Details
2.13.2 Zhifei Biologic Major Business
2.13.3 Zhifei Biologic Pneumonia Vaccine Product and Services
2.13.4 Zhifei Biologic Pneumonia Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Zhifei Biologic Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PNEUMONIA VACCINE BY MANUFACTURER
3.1 Global Pneumonia Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Pneumonia Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Pneumonia Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Pneumonia Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Pneumonia Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Pneumonia Vaccine Manufacturer Market Share in 2023
3.5 Pneumonia Vaccine Market: Overall Company Footprint Analysis
3.5.1 Pneumonia Vaccine Market: Region Footprint
3.5.2 Pneumonia Vaccine Market: Company Product Type Footprint
3.5.3 Pneumonia Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Pneumonia Vaccine Market Size by Region
4.1.1 Global Pneumonia Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Pneumonia Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Pneumonia Vaccine Average Price by Region (2019-2030)
4.2 North America Pneumonia Vaccine Consumption Value (2019-2030)
4.3 Europe Pneumonia Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Pneumonia Vaccine Consumption Value (2019-2030)
4.5 South America Pneumonia Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Pneumonia Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Pneumonia Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Pneumonia Vaccine Consumption Value by Type (2019-2030)
5.3 Global Pneumonia Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Pneumonia Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Pneumonia Vaccine Consumption Value by Application (2019-2030)
6.3 Global Pneumonia Vaccine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Pneumonia Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Pneumonia Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Pneumonia Vaccine Market Size by Country
7.3.1 North America Pneumonia Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Pneumonia Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Pneumonia Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Pneumonia Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Pneumonia Vaccine Market Size by Country
8.3.1 Europe Pneumonia Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Pneumonia Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Pneumonia Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Pneumonia Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Pneumonia Vaccine Market Size by Region
9.3.1 Asia-Pacific Pneumonia Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Pneumonia Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Pneumonia Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Pneumonia Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Pneumonia Vaccine Market Size by Country
10.3.1 South America Pneumonia Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Pneumonia Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Pneumonia Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Pneumonia Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Pneumonia Vaccine Market Size by Country
11.3.1 Middle East & Africa Pneumonia Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Pneumonia Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Pneumonia Vaccine Market Drivers
12.2 Pneumonia Vaccine Market Restraints
12.3 Pneumonia Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Pneumonia Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pneumonia Vaccine
13.3 Pneumonia Vaccine Production Process
13.4 Pneumonia Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pneumonia Vaccine Typical Distributors
14.3 Pneumonia Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Pneumonia Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Pneumonia Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Inc. Major Business
Table 5. Pfizer Inc. Pneumonia Vaccine Product and Services
Table 6. Pfizer Inc. Pneumonia Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Pfizer Inc. Recent Developments/Updates
Table 8. Glaxosmithkline Plc. Basic Information, Manufacturing Base and Competitors
Table 9. Glaxosmithkline Plc. Major Business
Table 10. Glaxosmithkline Plc. Pneumonia Vaccine Product and Services
Table 11. Glaxosmithkline Plc. Pneumonia Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Glaxosmithkline Plc. Recent Developments/Updates
Table 13. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 14. Merck & Co., Inc. Major Business
Table 15. Merck & Co., Inc. Pneumonia Vaccine Product and Services
Table 16. Merck & Co., Inc. Pneumonia Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Merck & Co., Inc. Recent Developments/Updates
Table 18. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 19. Sanofi Pasteur Major Business
Table 20. Sanofi Pasteur Pneumonia Vaccine Product and Services
Table 21. Sanofi Pasteur Pneumonia Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Sanofi Pasteur Recent Developments/Updates
Table 23. Serum Institute of India Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Serum Institute of India Pvt. Ltd. Major Business
Table 25. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Product and Services
Table 26. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Serum Institute of India Pvt. Ltd. Recent Developments/Updates
Table 28. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 29. Johnson & Johnson Major Business
Table 30. Johnson & Johnson Pneumonia Vaccine Product and Services
Table 31. Johnson & Johnson Pneumonia Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Johnson & Johnson Recent Developments/Updates
Table 33. Astellas Pharma Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Astellas Pharma Inc. Major Business
Table 35. Astellas Pharma Inc. Pneumonia Vaccine Product and Services
Table 36. Astellas Pharma Inc. Pneumonia Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Astellas Pharma Inc. Recent Developments/Updates
Table 38. Astrazeneca Plc. Basic Information, Manufacturing Base and Competitors
Table 39. Astrazeneca Plc. Major Business
Table 40. Astrazeneca Plc. Pneumonia Vaccine Product and Services
Table 41. Astrazeneca Plc. Pneumonia Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Astrazeneca Plc. Recent Developments/Updates
Table 43. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 44. CSL Limited Major Business
Table 45. CSL Limited Pneumonia Vaccine Product and Services
Table 46. CSL Limited Pneumonia Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. CSL Limited Recent Developments/Updates
Table 48. Emergent Biosolutions Basic Information, Manufacturing Base and Competitors
Table 49. Emergent Biosolutions Major Business
Table 50. Emergent Biosolutions Pneumonia Vaccine Product and Services
Table 51. Emergent Biosolutions Pneumonia Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Emergent Biosolutions Recent Developments/Updates
Table 53. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 54. Walvax Biotechnology Major Business
Table 55. Walvax Biotechnology Pneumonia Vaccine Product and Services
Table 56. Walvax Biotechnology Pneumonia Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Walvax Biotechnology Recent Developments/Updates
Table 58. Royal (Wuxi) Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 59. Royal (Wuxi) Bio-Pharmaceutical Major Business
Table 60. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Product and Services
Table 61. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Royal (Wuxi) Bio-Pharmaceutical Recent Developments/Updates
Table 63. Zhifei Biologic Basic Information, Manufacturing Base and Competitors
Table 64. Zhifei Biologic Major Business
Table 65. Zhifei Biologic Pneumonia Vaccine Product and Services
Table 66. Zhifei Biologic Pneumonia Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Zhifei Biologic Recent Developments/Updates
Table 68. Global Pneumonia Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Doses)
Table 69. Global Pneumonia Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 70. Global Pneumonia Vaccine Average Price by Manufacturer (2019-2024) & (USD/Dose)
Table 71. Market Position of Manufacturers in Pneumonia Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 72. Head Office and Pneumonia Vaccine Production Site of Key Manufacturer
Table 73. Pneumonia Vaccine Market: Company Product Type Footprint
Table 74. Pneumonia Vaccine Market: Company Product Application Footprint
Table 75. Pneumonia Vaccine New Market Entrants and Barriers to Market Entry
Table 76. Pneumonia Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Pneumonia Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
Table 78. Global Pneumonia Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
Table 79. Global Pneumonia Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 80. Global Pneumonia Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 81. Global Pneumonia Vaccine Average Price by Region (2019-2024) & (USD/Dose)
Table 82. Global Pneumonia Vaccine Average Price by Region (2025-2030) & (USD/Dose)
Table 83. Global Pneumonia Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 84. Global Pneumonia Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 85. Global Pneumonia Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 86. Global Pneumonia Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 87. Global Pneumonia Vaccine Average Price by Type (2019-2024) & (USD/Dose)
Table 88. Global Pneumonia Vaccine Average Price by Type (2025-2030) & (USD/Dose)
Table 89. Global Pneumonia Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 90. Global Pneumonia Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 91. Global Pneumonia Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 92. Global Pneumonia Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 93. Global Pneumonia Vaccine Average Price by Application (2019-2024) & (USD/Dose)
Table 94. Global Pneumonia Vaccine Average Price by Application (2025-2030) & (USD/Dose)
Table 95. North America Pneumonia Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 96. North America Pneumonia Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 97. North America Pneumonia Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 98. North America Pneumonia Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 99. North America Pneumonia Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
Table 100. North America Pneumonia Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
Table 101. North America Pneumonia Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 102. North America Pneumonia Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 103. Europe Pneumonia Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 104. Europe Pneumonia Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 105. Europe Pneumonia Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 106. Europe Pneumonia Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 107. Europe Pneumonia Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
Table 108. Europe Pneumonia Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
Table 109. Europe Pneumonia Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 110. Europe Pneumonia Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 111. Asia-Pacific Pneumonia Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 112. Asia-Pacific Pneumonia Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 113. Asia-Pacific Pneumonia Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 114. Asia-Pacific Pneumonia Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 115. Asia-Pacific Pneumonia Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
Table 116. Asia-Pacific Pneumonia Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
Table 117. Asia-Pacific Pneumonia Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 118. Asia-Pacific Pneumonia Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 119. South America Pneumonia Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 120. South America Pneumonia Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 121. South America Pneumonia Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 122. South America Pneumonia Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 123. South America Pneumonia Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
Table 124. South America Pneumonia Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
Table 125. South America Pneumonia Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 126. South America Pneumonia Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 127. Middle East & Africa Pneumonia Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 128. Middle East & Africa Pneumonia Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 129. Middle East & Africa Pneumonia Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 130. Middle East & Africa Pneumonia Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 131. Middle East & Africa Pneumonia Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
Table 132. Middle East & Africa Pneumonia Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
Table 133. Middle East & Africa Pneumonia Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 134. Middle East & Africa Pneumonia Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 135. Pneumonia Vaccine Raw Material
Table 136. Key Manufacturers of Pneumonia Vaccine Raw Materials
Table 137. Pneumonia Vaccine Typical Distributors
Table 138. Pneumonia Vaccine Typical Customers
Table 1. Global Pneumonia Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Pneumonia Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Inc. Major Business
Table 5. Pfizer Inc. Pneumonia Vaccine Product and Services
Table 6. Pfizer Inc. Pneumonia Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Pfizer Inc. Recent Developments/Updates
Table 8. Glaxosmithkline Plc. Basic Information, Manufacturing Base and Competitors
Table 9. Glaxosmithkline Plc. Major Business
Table 10. Glaxosmithkline Plc. Pneumonia Vaccine Product and Services
Table 11. Glaxosmithkline Plc. Pneumonia Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Glaxosmithkline Plc. Recent Developments/Updates
Table 13. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 14. Merck & Co., Inc. Major Business
Table 15. Merck & Co., Inc. Pneumonia Vaccine Product and Services
Table 16. Merck & Co., Inc. Pneumonia Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Merck & Co., Inc. Recent Developments/Updates
Table 18. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 19. Sanofi Pasteur Major Business
Table 20. Sanofi Pasteur Pneumonia Vaccine Product and Services
Table 21. Sanofi Pasteur Pneumonia Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Sanofi Pasteur Recent Developments/Updates
Table 23. Serum Institute of India Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Serum Institute of India Pvt. Ltd. Major Business
Table 25. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Product and Services
Table 26. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Serum Institute of India Pvt. Ltd. Recent Developments/Updates
Table 28. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 29. Johnson & Johnson Major Business
Table 30. Johnson & Johnson Pneumonia Vaccine Product and Services
Table 31. Johnson & Johnson Pneumonia Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Johnson & Johnson Recent Developments/Updates
Table 33. Astellas Pharma Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Astellas Pharma Inc. Major Business
Table 35. Astellas Pharma Inc. Pneumonia Vaccine Product and Services
Table 36. Astellas Pharma Inc. Pneumonia Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Astellas Pharma Inc. Recent Developments/Updates
Table 38. Astrazeneca Plc. Basic Information, Manufacturing Base and Competitors
Table 39. Astrazeneca Plc. Major Business
Table 40. Astrazeneca Plc. Pneumonia Vaccine Product and Services
Table 41. Astrazeneca Plc. Pneumonia Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Astrazeneca Plc. Recent Developments/Updates
Table 43. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 44. CSL Limited Major Business
Table 45. CSL Limited Pneumonia Vaccine Product and Services
Table 46. CSL Limited Pneumonia Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. CSL Limited Recent Developments/Updates
Table 48. Emergent Biosolutions Basic Information, Manufacturing Base and Competitors
Table 49. Emergent Biosolutions Major Business
Table 50. Emergent Biosolutions Pneumonia Vaccine Product and Services
Table 51. Emergent Biosolutions Pneumonia Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Emergent Biosolutions Recent Developments/Updates
Table 53. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 54. Walvax Biotechnology Major Business
Table 55. Walvax Biotechnology Pneumonia Vaccine Product and Services
Table 56. Walvax Biotechnology Pneumonia Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Walvax Biotechnology Recent Developments/Updates
Table 58. Royal (Wuxi) Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 59. Royal (Wuxi) Bio-Pharmaceutical Major Business
Table 60. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Product and Services
Table 61. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Royal (Wuxi) Bio-Pharmaceutical Recent Developments/Updates
Table 63. Zhifei Biologic Basic Information, Manufacturing Base and Competitors
Table 64. Zhifei Biologic Major Business
Table 65. Zhifei Biologic Pneumonia Vaccine Product and Services
Table 66. Zhifei Biologic Pneumonia Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Zhifei Biologic Recent Developments/Updates
Table 68. Global Pneumonia Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Doses)
Table 69. Global Pneumonia Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 70. Global Pneumonia Vaccine Average Price by Manufacturer (2019-2024) & (USD/Dose)
Table 71. Market Position of Manufacturers in Pneumonia Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 72. Head Office and Pneumonia Vaccine Production Site of Key Manufacturer
Table 73. Pneumonia Vaccine Market: Company Product Type Footprint
Table 74. Pneumonia Vaccine Market: Company Product Application Footprint
Table 75. Pneumonia Vaccine New Market Entrants and Barriers to Market Entry
Table 76. Pneumonia Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Pneumonia Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
Table 78. Global Pneumonia Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
Table 79. Global Pneumonia Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 80. Global Pneumonia Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 81. Global Pneumonia Vaccine Average Price by Region (2019-2024) & (USD/Dose)
Table 82. Global Pneumonia Vaccine Average Price by Region (2025-2030) & (USD/Dose)
Table 83. Global Pneumonia Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 84. Global Pneumonia Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 85. Global Pneumonia Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 86. Global Pneumonia Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 87. Global Pneumonia Vaccine Average Price by Type (2019-2024) & (USD/Dose)
Table 88. Global Pneumonia Vaccine Average Price by Type (2025-2030) & (USD/Dose)
Table 89. Global Pneumonia Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 90. Global Pneumonia Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 91. Global Pneumonia Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 92. Global Pneumonia Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 93. Global Pneumonia Vaccine Average Price by Application (2019-2024) & (USD/Dose)
Table 94. Global Pneumonia Vaccine Average Price by Application (2025-2030) & (USD/Dose)
Table 95. North America Pneumonia Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 96. North America Pneumonia Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 97. North America Pneumonia Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 98. North America Pneumonia Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 99. North America Pneumonia Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
Table 100. North America Pneumonia Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
Table 101. North America Pneumonia Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 102. North America Pneumonia Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 103. Europe Pneumonia Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 104. Europe Pneumonia Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 105. Europe Pneumonia Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 106. Europe Pneumonia Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 107. Europe Pneumonia Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
Table 108. Europe Pneumonia Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
Table 109. Europe Pneumonia Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 110. Europe Pneumonia Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 111. Asia-Pacific Pneumonia Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 112. Asia-Pacific Pneumonia Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 113. Asia-Pacific Pneumonia Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 114. Asia-Pacific Pneumonia Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 115. Asia-Pacific Pneumonia Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
Table 116. Asia-Pacific Pneumonia Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
Table 117. Asia-Pacific Pneumonia Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 118. Asia-Pacific Pneumonia Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 119. South America Pneumonia Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 120. South America Pneumonia Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 121. South America Pneumonia Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 122. South America Pneumonia Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 123. South America Pneumonia Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
Table 124. South America Pneumonia Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
Table 125. South America Pneumonia Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 126. South America Pneumonia Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 127. Middle East & Africa Pneumonia Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 128. Middle East & Africa Pneumonia Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 129. Middle East & Africa Pneumonia Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 130. Middle East & Africa Pneumonia Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 131. Middle East & Africa Pneumonia Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
Table 132. Middle East & Africa Pneumonia Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
Table 133. Middle East & Africa Pneumonia Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 134. Middle East & Africa Pneumonia Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 135. Pneumonia Vaccine Raw Material
Table 136. Key Manufacturers of Pneumonia Vaccine Raw Materials
Table 137. Pneumonia Vaccine Typical Distributors
Table 138. Pneumonia Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Pneumonia Vaccine Picture
Figure 2. Global Pneumonia Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Pneumonia Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Pneumococcal Conjugate Vaccine (PCV13) Examples
Figure 5. Pneumococcal Polysaccharide Vaccine (PPSV23) Examples
Figure 6. Other Examples
Figure 7. Global Pneumonia Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 8. Global Pneumonia Vaccine Consumption Value Market Share by Application in 2023
Figure 9. Pneumonia Examples
Figure 10. Meningitis Examples
Figure 11. Sepsis Examples
Figure 12. Global Pneumonia Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Pneumonia Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Pneumonia Vaccine Sales Quantity (2019-2030) & (K Doses)
Figure 15. Global Pneumonia Vaccine Average Price (2019-2030) & (USD/Dose)
Figure 16. Global Pneumonia Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Pneumonia Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Pneumonia Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Pneumonia Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Pneumonia Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Pneumonia Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Pneumonia Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Pneumonia Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Pneumonia Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Pneumonia Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Pneumonia Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Pneumonia Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Pneumonia Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Pneumonia Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Pneumonia Vaccine Average Price by Type (2019-2030) & (USD/Dose)
Figure 31. Global Pneumonia Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Pneumonia Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Pneumonia Vaccine Average Price by Application (2019-2030) & (USD/Dose)
Figure 34. North America Pneumonia Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Pneumonia Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Pneumonia Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Pneumonia Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Pneumonia Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Pneumonia Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Pneumonia Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Pneumonia Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Pneumonia Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Pneumonia Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Pneumonia Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Pneumonia Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 54. China Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Pneumonia Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Pneumonia Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Pneumonia Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Pneumonia Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Pneumonia Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Pneumonia Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Pneumonia Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Pneumonia Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Pneumonia Vaccine Market Drivers
Figure 75. Pneumonia Vaccine Market Restraints
Figure 76. Pneumonia Vaccine Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Pneumonia Vaccine in 2023
Figure 79. Manufacturing Process Analysis of Pneumonia Vaccine
Figure 80. Pneumonia Vaccine Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Pneumonia Vaccine Picture
Figure 2. Global Pneumonia Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Pneumonia Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Pneumococcal Conjugate Vaccine (PCV13) Examples
Figure 5. Pneumococcal Polysaccharide Vaccine (PPSV23) Examples
Figure 6. Other Examples
Figure 7. Global Pneumonia Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 8. Global Pneumonia Vaccine Consumption Value Market Share by Application in 2023
Figure 9. Pneumonia Examples
Figure 10. Meningitis Examples
Figure 11. Sepsis Examples
Figure 12. Global Pneumonia Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Pneumonia Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Pneumonia Vaccine Sales Quantity (2019-2030) & (K Doses)
Figure 15. Global Pneumonia Vaccine Average Price (2019-2030) & (USD/Dose)
Figure 16. Global Pneumonia Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Pneumonia Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Pneumonia Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Pneumonia Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Pneumonia Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Pneumonia Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Pneumonia Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Pneumonia Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Pneumonia Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Pneumonia Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Pneumonia Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Pneumonia Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Pneumonia Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Pneumonia Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Pneumonia Vaccine Average Price by Type (2019-2030) & (USD/Dose)
Figure 31. Global Pneumonia Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Pneumonia Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Pneumonia Vaccine Average Price by Application (2019-2030) & (USD/Dose)
Figure 34. North America Pneumonia Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Pneumonia Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Pneumonia Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Pneumonia Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Pneumonia Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Pneumonia Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Pneumonia Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Pneumonia Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Pneumonia Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Pneumonia Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Pneumonia Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Pneumonia Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 54. China Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Pneumonia Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Pneumonia Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Pneumonia Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Pneumonia Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Pneumonia Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Pneumonia Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Pneumonia Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Pneumonia Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Pneumonia Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Pneumonia Vaccine Market Drivers
Figure 75. Pneumonia Vaccine Market Restraints
Figure 76. Pneumonia Vaccine Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Pneumonia Vaccine in 2023
Figure 79. Manufacturing Process Analysis of Pneumonia Vaccine
Figure 80. Pneumonia Vaccine Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
